Neoprobe names new chief development officer

11/18/2010 | MedCityNews.com

Neoprobe has designated Mark Pykett as its new chief development officer. Pykett was the founder of Talaris Advisors and was chief operating officer at Alseres Pharmaceuticals. Pykett will help the company in securing approval for its tracing agent Lymphoseek, as well as determine a collaborating firm for RIGScan, another tracing agent still in early development stages.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA